BDBM621863 (S)-N-((R or S)-(3- chloro-2,4- difluorophenyl)(2- (2,2,2- trifluoroethoxy)thiazol- 5-yl)methyl)-2- oxoimidazolidine-4- carboxamide::US20230312528, Example 35A

SMILES Fc1ccc([C@@H](NC(=O)[C@@H]2CNC(=O)N2)c2cnc(OCC(F)(F)F)s2)c(F)c1Cl

InChI Key InChIKey=ALMNSEVIEVBIQP-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 621863   

TargetSodium channel protein type 8 subunit alpha(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM621863(US20230312528, Example 35A | (S)-N-((R or S)-(3- c...)
Affinity DataIC50: 2.40nMAssay Description:Compounds were tested on human NaV1.8 and NaV1.5 channels stably expressed in human embryo kidney (HEK) 293 cells. Sodium current measurements on Qub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
US Patent